Theravance Biopharma Inc
NASDAQ:TBPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Theravance Biopharma Inc
NASDAQ:TBPH
|
KY |
|
H
|
HB Technology Co Ltd
KOSDAQ:078150
|
KR |
|
Balance Labs Inc
OTC:BLNC
|
US |
|
Aneka Tambang Tbk PT
IDX:ANTM
|
ID |
|
APM Human Services International Ltd
ASX:APM
|
AU |
|
A
|
Avantel Ltd
BSE:532406
|
IN |
|
Pareto Bank ASA
OSE:PARB
|
NO |
|
I G Petrochemicals Ltd
NSE:IGPL
|
IN |
|
D
|
Deep Value Driller AS
OSE:DVD
|
NO |
|
CDT Environmental Technology Investment Holdings Ltd
NASDAQ:CDTG
|
CN |
|
V
|
Viet Phat Import Export Trading Investment JSC
VN:VPG
|
VN |
|
M
|
Master-Pack Group Bhd
KLSE:MASTER
|
MY |
|
Eestech Inc
OTC:EESH
|
US |
|
M
|
Microsoft Corp
BMV:MSFT
|
US |
|
Texas Roadhouse Inc
NASDAQ:TXRH
|
US |
|
B
|
Bualuang Office Leasehold Real Estate Investment Trust
SET:B-WORK
|
TH |
|
S
|
Synnex (Thailand) PCL
SET:SYNEX
|
TH |
|
Risanamento SpA
MIL:RN
|
IT |
|
A
|
Anglo African Agriculture PLC
LSE:AAAP
|
UK |
|
Prothena Corporation PLC
NASDAQ:PRTA
|
IE |
|
W
|
WLS Holdings Ltd
HKEX:8021
|
HK |
|
G
|
Genexine Inc
KOSDAQ:095700
|
KR |
|
E
|
Excel Realty N Infra Ltd
BSE:533090
|
IN |
Shareholder Yield
Current shareholder yield for TBPH is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
TBPH Price
Theravance Biopharma Inc
| Average Annual Return | -16.58% |
| Standard Deviation of Annual Returns | 19.62% |
| Max Drawdown | -70% |
| Market Capitalization | 838.6m USD |
| Shares Outstanding | 50 670 000 |
| Percentage of Shares Shorted | 15.91% |
